Evaluation of EuroSCORE II to Determine the Prognosis of Patients With Moderate-To-Severe Aortic Stenosis: A Long-Term Retrospective Study.
Xianzhen Cai, Danchun Hu, Baoxin Yan...
https://pubmed.ncbi.nlm.nih.gov/41789337/Actively Recruiting
Led by Sun Yat-sen University · Updated on 2023-10-12
2000
Participants Needed
7
Research Sites
N/A
Total Duration
This research aims to better understand patients diagnosed with aortic valve disease, including aortic insufficiency and aortic valve stenosis, during hospitalization. The study is a multicenter cohort study focused on evaluating risk factors that affect patient outcomes. Researchers will use this information to develop a model that can help guide clinical decisions for people with these heart valve conditions. Participants diagnosed with aortic valve disease will be followed over time to observe their health outcomes. The study will monitor events such as all-cause death and cardiovascular complications, including whether patients undergo aortic valve replacement. No specific treatments or interventions are assigned, as this is an observational study. During the study, participants will be observed from baseline until death or the end of the follow-up period. Researchers will collect data on mortality and cardiovascular events to analyze prognostic risk factors. The primary outcome is all-cause mortality, while secondary outcomes include cardiovascular death and valve replacement. This ongoing observation will help improve understanding of the disease progression and patient prognosis.
CONDITIONS
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
X
xiaodong zhuang, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Sun Yat-sen University
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to approximately 5 years until study completion
Participants are observed over time to assess outcomes related to aortic valve disease.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Xianzhen Cai, Danchun Hu, Baoxin Yan...
https://pubmed.ncbi.nlm.nih.gov/41789337/Bingzhen Li, Shaozhao Zhang, Chaoguang Xu...
https://pubmed.ncbi.nlm.nih.gov/39895526/Zhen Guo, Zhenyu Xiong, Lixiang He...
https://pubmed.ncbi.nlm.nih.gov/39881345/Zhen Guo, Zhenyu Xiong, Wenjing Zhang...
https://pubmed.ncbi.nlm.nih.gov/41076530/Sun Yat-sen University
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Collaborating Sponsor